SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from TRINITY BIOTECH PLC (TRIB) (CIK 0000888721) (TRIB) — May 20, 2005

TRINITY BIOTECH PLC (TRIB) (CIK 0000888721)
Date: May 20, 2005 · CIK: 0000888721 · Accession: 0001125282-05-002728

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-124385

Date
May 20, 2005
Author
Chief
Form
CORRESP
Company
TRINITY BIOTECH PLC (TRIB) (CIK 0000888721)

Letter

Securities and Exchange Commission Washington, D.C. 20549 Attention: Mr. Dan Greenspan, Esq. Re: Trinity Biotech plc File No. 333-124385

Dear Mr. Greenspan:

On behalf of our company, I request that the above referenced Registration Statement be declared effective by the Securities and Exchange Commission at 3:00 p.m. on May 20, 2005. Management of our company is aware of their responsibilities under the Securities Act of 1933 as they relate to the disposition of the securities covered by the above referenced Registration Statement. We hereby acknowledge that:

(i) should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

(ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

(iii) the company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Thank you very much for your courtesy in this matter.

Very truly yours,
/s/
Rory Nealon

Show Raw Text
CORRESP
1
filename1.htm

Prepared and filed by St Ives Burrups

TRINITY BIOTECH PLC

IDA Business Park

Bray, Co. Wicklow

Ireland

Tel:  011 353 1 276 9800

May 20, 2005

BY FACSIMILE

Securities and Exchange Commission

450 Fifth Street, N.W.

Judiciary Plaza

Washington, D.C.  20549

Attention:  Mr. Dan Greenspan, Esq.

          Re:      Trinity Biotech plc

                      File No. 333-124385

Dear Mr. Greenspan:

     On behalf of our company, I request that the above referenced Registration Statement be declared effective by the Securities and Exchange Commission at 3:00 p.m. on May 20, 2005.                Management of our company is aware of their responsibilities under the Securities Act of 1933 as they relate to the disposition of the securities covered by the above referenced Registration Statement.  We hereby acknowledge that:

     (i)    should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

     (ii)   the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

     (iii)    the company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

     Thank you very much for your courtesy in this matter.

Very truly yours,

/s/
      Rory Nealon

    Rory
    Nealon

    Chief
    Financial Officer